227 related articles for article (PubMed ID: 21155039)
1. The role of 18F-FDG PET/CT in the evaluation of gastric cancer recurrence after curative gastrectomy.
Lee JE; Hong SP; Ahn DH; Jeon TJ; Kang MK; Kwon CI; Ko KH; Hwang SG; Park PW; Rim KS
Yonsei Med J; 2011 Jan; 52(1):81-8. PubMed ID: 21155039
[TBL] [Abstract][Full Text] [Related]
2. Performance of (18)F-FDG PET/CT as a postoperative surveillance imaging modality for asymptomatic advanced gastric cancer patients.
Lee DY; Lee CH; Seo MJ; Lee SH; Ryu JS; Lee JJ
Ann Nucl Med; 2014 Oct; 28(8):789-95. PubMed ID: 24965850
[TBL] [Abstract][Full Text] [Related]
3. The role of ¹⁸F-FDG PET/CT in the assessment of suspected recurrent gastric cancer after initial surgical resection: can the results of FDG PET/CT influence patients' treatment decision making?
Bilici A; Ustaalioglu BB; Seker M; Kefeli U; Canpolat N; Tekinsoy B; Ozugur S; Gumus M
Eur J Nucl Med Mol Imaging; 2011 Jan; 38(1):64-73. PubMed ID: 20838995
[TBL] [Abstract][Full Text] [Related]
4. Lymph node staging of gastric cancer using (18)F-FDG PET: a comparison study with CT.
Yun M; Lim JS; Noh SH; Hyung WJ; Cheong JH; Bong JK; Cho A; Lee JD
J Nucl Med; 2005 Oct; 46(10):1582-8. PubMed ID: 16204706
[TBL] [Abstract][Full Text] [Related]
5. Primary Tumor ¹⁸F-FDG Avidity Affects the Performance of ¹⁸F-FDG PET/CT for Detecting Gastric Cancer Recurrence.
Kim SJ; Cho YS; Moon SH; Bae JM; Kim S; Choe YS; Kim BT; Lee KH
J Nucl Med; 2016 Apr; 57(4):544-50. PubMed ID: 26678615
[TBL] [Abstract][Full Text] [Related]
6. Role of 2-[18F] fluoro-2-deoxy-D-glucose-positron emission tomography/computed tomography in the post-therapy surveillance of breast cancer.
Chang HT; Hu C; Chiu YL; Peng NJ; Liu RS
PLoS One; 2014; 9(12):e115127. PubMed ID: 25517451
[TBL] [Abstract][Full Text] [Related]
7. Detecting the recurrence of gastric cancer after curative resection: comparison of FDG PET/CT and contrast-enhanced abdominal CT.
Kim DW; Park SA; Kim CG
J Korean Med Sci; 2011 Jul; 26(7):875-80. PubMed ID: 21738339
[TBL] [Abstract][Full Text] [Related]
8. Clinical value of F18-fluorodeoxyglucose positron emission tomography-computed tomography in patients with non-small cell lung cancer after potentially curative surgery: experience with 241 patients.
Kanzaki R; Higashiyama M; Maeda J; Okami J; Hosoki T; Hasegawa Y; Takami M; Kodama K
Interact Cardiovasc Thorac Surg; 2010 Jun; 10(6):1009-14. PubMed ID: 20197344
[TBL] [Abstract][Full Text] [Related]
9. Clinical usefulness of F-18 FDG PET in lymphoepithelioma-like gastric carcinoma.
Park S; Lee D; Lee KM; Han SU; Lee JH; Lee SJ; An YS; Yoon JK
Eur J Radiol; 2017 Sep; 94():160-166. PubMed ID: 28712702
[TBL] [Abstract][Full Text] [Related]
10. Diagnostic performance of FDG PET/CT for surveillance in asymptomatic gastric cancer patients after curative surgical resection.
Lee JW; Lee SM; Son MW; Lee MS
Eur J Nucl Med Mol Imaging; 2016 May; 43(5):881-888. PubMed ID: 26611426
[TBL] [Abstract][Full Text] [Related]
11. [F-18]fluorodeoxyglucose positron emission tomography and positron emission tomography: computed tomography in recurrent and metastatic cholangiocarcinoma.
Jadvar H; Henderson RW; Conti PS
J Comput Assist Tomogr; 2007; 31(2):223-8. PubMed ID: 17414758
[TBL] [Abstract][Full Text] [Related]
12. [Clinical application of (18)F-FDG PET/CT to staging and treatment effectiveness monitoring of nasopharyngeal carcinoma].
Wang GH; Lau EW; Shakher R; Binns DS; Hogg A; Drummond E; Hicks RJ
Ai Zheng; 2007 Jun; 26(6):638-42. PubMed ID: 17562272
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of recurrence in gastric carcinoma: Comparison of contrast-enhanced computed tomography and positron emission tomography/computed tomography.
Kim JH; Heo SH; Kim JW; Shin SS; Min JJ; Kwon SY; Jeong YY; Kang HK
World J Gastroenterol; 2017 Sep; 23(35):6448-6456. PubMed ID: 29085194
[TBL] [Abstract][Full Text] [Related]
14. The role of gastric distention in differentiating recurrent tumor from physiologic uptake in the remnant stomach on 18F-FDG PET.
Yun M; Choi HS; Yoo E; Bong JK; Ryu YH; Lee JD
J Nucl Med; 2005 Jun; 46(6):953-7. PubMed ID: 15937305
[TBL] [Abstract][Full Text] [Related]
15. Can (18)F-FDG PET/CT scan change treatment planning and be prognostic in recurrent colorectal carcinoma? A prospective and follow-up study.
Artiko V; Odalovic S; Sobic-Saranovic D; Petrovic M; Stojiljkovic M; Petrovic N; Kozarevic N; Grozdic-Milojevic I; Obradovic V
Hell J Nucl Med; 2015; 18(1):35-41. PubMed ID: 25840571
[TBL] [Abstract][Full Text] [Related]
16. The role of PET/CT in detection of gastric cancer recurrence.
Sim SH; Kim YJ; Oh DY; Lee SH; Kim DW; Kang WJ; Im SA; Kim TY; Kim WH; Heo DS; Bang YJ
BMC Cancer; 2009 Mar; 9():73. PubMed ID: 19250554
[TBL] [Abstract][Full Text] [Related]
17. Role of ¹⁸F-FDG PET/CT in the prediction of gastric cancer recurrence after curative surgical resection.
Lee JW; Lee SM; Lee MS; Shin HC
Eur J Nucl Med Mol Imaging; 2012 Sep; 39(9):1425-34. PubMed ID: 22673973
[TBL] [Abstract][Full Text] [Related]
18. Assessment of lymph node metastases using 18F-FDG PET in patients with advanced gastric cancer.
Kim SK; Kang KW; Lee JS; Kim HK; Chang HJ; Choi JY; Lee JH; Ryu KW; Kim YW; Bae JM
Eur J Nucl Med Mol Imaging; 2006 Feb; 33(2):148-55. PubMed ID: 16228236
[TBL] [Abstract][Full Text] [Related]
19. Clinical role of 18F-fluorodeoxyglucose positron emission tomography/computed tomography in post-operative follow up of gastric cancer: initial results.
Sun L; Su XH; Guan YS; Pan WM; Luo ZM; Wei JH; Wu H
World J Gastroenterol; 2008 Aug; 14(29):4627-32. PubMed ID: 18698676
[TBL] [Abstract][Full Text] [Related]
20. Routinely staging gastric cancer with
Findlay JM; Antonowicz S; Segaran A; El Kafsi J; Zhang A; Bradley KM; Gillies RS; Maynard ND; Middleton MR
Eur Radiol; 2019 May; 29(5):2490-2498. PubMed ID: 30643947
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
